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Abstract 
Lab-on-a-chip systems for point-of-care testing demonstrate a promising development 
towards more accurate diagnostic tests that are of extreme importance for the future 
global health. This work presents an agglutination assay performed in micrometer 
sized well using Janus PS/Ag/AgCl micromotors to enhance the interactions between 
goat anti-human IgM functionalized particles and Human IgM. The fabricated 
microwell chips are a suitable platform to analyze the interaction between different 
particles and to perform the agglutination assays. The interaction between active 
Janus particles and passive and functionalized particles is studied, as well as the 
influence of ions on the motion of the Janus particles. Agglutination assays are 
performed with and without the presence of Janus particles, and in different PBS 
concentrations. Once illuminated with blue light, passive SiO2 particles were 
effectively excluded from Janus particles, while SiO2–NH2 particles revealed 
attraction. In contrast, functionalized SiO2–NH2-Ab particles suspended in PBS did 
not show any interaction. It was found that the optimal working conditions for 
antibodies and Janus particles differed and, as a result, the Janus particles did not 
reveal a desirable interaction between the functionalized particles and IgM. Further 
experiments should be performed to find the proper conditions in which the antibodies 
and the Janus particles maintain their activities. It is believed that an effective 
interaction between the functionalized and Janus particles could be achieved by 
modifying the parameters that affect their interaction such as the zeta potential and the 
medium in which the assay is being performed. This preliminary work provides the 
first steps towards the development of a fully-integrated lab-on-a-chip system for 
point-of-care testing. 
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1. Introduction 
Medical diagnosis is a key aspect of human health care. It attempts to determine the 
cause of the symptoms experienced by a person by means of an evaluation of the 
patient’s history and a physical examination1. However, considering that most of the 
symptoms are not specific to particular disease, other procedures such as diagnostic 
tests should be performed to discern between diseases or conditions that produce very 
similar behaviors. Therefore, the use of diagnostic tests has become an essential 
element of the medical diagnosis process2. 
1.1 In vitro diagnostic tests 
In vitro diagnostic tests are one of the most used tests in assisting the medical 
diagnosis process3,4. This type of tests examine specimens from the human body such 
as blood, serum, saliva, urine and tissue3–5. Since in vitro diagnostics is fundamental 
for early detection, monitoring the stages of a disease, and accurate prognosis, there is 
a need to develop more accurate tests that at the same time can fulfill the requirements 
of global health6. 
 
The challenges of the development of diagnostic tests arise from the fact that diseases 
can be originated by different factors such as specific gene mutations or infections 
caused by parasites, bacteria or viruses7–10. In addition, the time for each disease to 
manifest symptoms can vary since, at early stages, the amount of bacteria or virus is 
not enough to produce an immune response9.  
 
Another important constrain to the design of diagnostic tests is that the access to 
health care facilities in which many of these tests are performed are not available for 
all the people in need of them. This can be due to the scarcity of specialized 
laboratories or to the elevated costs11. For that reason, it is important to develop 
diagnostic tests that do not need specialized equipment and that can be performed at 
the place of patient care2. 
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1.1.1 Point-of-care tests  
Point-of-care (POC) tests refer to tests that can be performed near or at the place 
where the patient is2,12. The idea of POC test is that they should be able to be used by 
the patient itself, this implies that the test should require minimum sample 
preparation, fast response, digital or visible readout and user-friendly equipment6. All 
these characteristics make POC tests very attractive since they would allow rapid 
clinical decision making, better disease monitoring, decrease costs, and allow them to 
be employed in places where there is no adequate infrastructure2,6,12.  
 
Lateral flow immunoassays (LFIA) are one of the most popular POC tests6,13. Their 
technical basis is derived from the latex agglutination assay first realized by Plotz and 
Singer in 195614. Among the LFIA, the pregnancy dipstick tests are the most widely 
used6. A typical LFIA strip and the operation of LFIA are shown in Figure 1.  
 
The principle of the LFIA is the following: a liquid sample is applied on an absorbent 
pad and moves through the test strip by capillary action interacting with molecules 
present in the test strip13. If the sample contains the analyte of interest it will interact 
with antibodies that are present in the conjugate release pad. These antibodies are 
conjugated to colored or fluorescent particles. The analyte of interest bounded to the 
conjugated antibodies will further migrate to the detection zone in which specific 
antigens or antibodies are immobilized. These will react with the analyte bound to 
conjugated antibodies. If there is recognition of the analyte of interest a colored test 
line will appear. However, a control line would always appear and it indicates a 
proper liquid flow through the test strip6,13. 
1.2 Agglutination assay 
Agglutination of cells or particles refers to the formation of clumps by the interaction 
of specific antibodies against the respective antigens present in the surface of the cells 
or the particles15. This reaction can be used to detect the presence of antibodies in 
human sera and body fluids15,16. Different antigens such as pathogens, bacteria, fungi, 
and viruses can also be detected15,17.  
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Figure 1. Lateral flow immunoassay. (A) Configuration of a lateral flow immunoassay test strip. (B) 
Schematic representation of the operation of the assay. Top: sample is deposited on the sample pad and 
migrates to the conjugated antibodies. Middle: the conjugated antibodies bind to the analyte. Bottom: 
migration of the bound target analyte to the test line where it is captured. (C) Pregnancy test (One Step 
hCG Urine Test) possible results and interpretation. Image adapted from Koczula and Gallotta13. 
 
Antigens form large agglomerates when the specific antibodies are present as a result 
of the several recognition sites that antibodies have16. These agglomerates are visible 
without magnification; however, to improve visualization, antibodies can be attached 
to the surface of latex particles. This assay is known as indirect agglutination assay or 
latex agglutination assay since the agglutination of the particles will be the indicator 
of the presence of the antigen in solution14,17. The latex agglutination assay can be 
used to detect either antigens or antibodies since the particles can be functionalized at 
convenience as it is presented in Figure 2. 
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Figure 2. Indirect agglutination assay. (A) Possitive agglutination test for antibodies and (B) possitive 
agglutination test for antigens18. 
 
Latex agglutination assays have been employed to detect different diseases such as 
rheumatoid arthritis, HIV, dengue, typhoid fever, and bladder tumors14,15,19–21. Some 
of the advantages of using this technique for diagnosis are the increased efficiency of 
antigen-antibody binding due to a large surface area compared to ELISA, decrease in 
assay time as a result of a high surface to volume ratio (increase reaction rate), and the 
possibility to perform the assay using different types of samples17.  On the other hand, 
some of the disadvantages that latex agglutination tests have are that sample 
preparation is required and the results are qualitative and semi-quantitative15. 
 
Overall, latex agglutination assays are of great interest to be implemented as POC 
tests since the equipment required to perform the assay is minimal compared to other 
techniques such as ELISA15,17. The use technologies such as lab-on-a-chip and 
biosensors could eliminate the sample preparation steps and give more accurate and 
quantitative results22,23. 
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1.3 Lab-on-a-chip 
The term lab-on-a-chip (LOC) is attributed to the miniaturization of one or more 
laboratory techniques into a small chip of up to few square centimeters in size24. 
Laboratory work at this scale is appealing since the time, reagents and waste are 
reduced25. The compact integration of the components such as biosensors and 
microfluidic elements, and the short analysis and response time due to shorter 
diffusion distances that can be achieve with LOC technology make them an important 
ally to the development of POC tests22. Figure 3 shows an example of the integration 
of several analytical techniques to develop a LOC system for POC testing. 
 
 
Figure 3. Lab-on-a-chip device for point-of-care testing26. 
 
Recent trends have suggested the integration of nanomaterials to LOC technology to 
improve the sensitivity and selectivity of the analytical operations due to the 
interesting surface properties that nanomaterials can exhibit25. Additionally, smart 
materials such as micro- and nanomotors that move by different propulsion 
mechanisms can perform interesting tasks such as cargo transport and induce the 
collective behavior of particles27–29. These characteristics can add different and more 
complex functionalities to the LOC technology. 
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1.4 Self-propelled particles 
Self-propelled particles, also known as microswimmers and micromotors, are 
microscale devices that have been especially designed to exhibit motion as a response 
to specific stimuli30. Their development was triggered by Feynman’s visionary talk in 
1959 in which he introduced the idea of small machines that could move and perform 
complex tasks31. 
 
Figure 4 shows some examples of microswimmers using different propulsion 
mechanisms. Bubble propulsion is one of the most studies mechanisms and it involves 
the decomposition of a fuel by a catalyst which results in the formation of gas bubbles 
leading to rocket-like propulsion32. Ultrasound can be used as an external stimulus to 
propel asymmetric particles since this asymmetry will induce the generation of 
pressure gradients that would lead them to move unidirectionally32.  Rotary external 
magnetic fields can propel magnetic helix by transforming the rotation around their 
axis into translational corkscrew motion33. Light can also be used as an external 
stimulus since it can induce phoretic self-propulsion by means of a photocatalytic 
reaction34. 
 
Microswimmers have demonstrated their functionalities in different applications such 
as cargo transport, environmental remediation, sensing, drug delivery, and imaging35. 
For each of these applications, microswimmers should meet certain requirements such 
as the use of biocompatible materials for biomedical applications. Of special interest 
are light-driven microswimmers since they have a fuel-free propulsion mechanism 
and have shown to act collectively and also induce collective behavior in other 
particles around them. These characteristics make them appealing for applications 
such as the transport and deliver of cargo28.  
1.4.1 Light-driven Ag/AgCl micromotors 
Wang et al., have reported the collective behavior of passive polystyrene (PS) beads 
induced by blue-light-actuated PS/Ag/AgCl Janus micromotors in pure water29. The 
plasmonic Ag/AgCl cap of the Janus micromotors enables them to absorb blue light 
which generates the photodecomposition of silver chloride as shown in Equation 1. 
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Figure 4. Microswimmmers and their different propulsion mechanisms. (A) Schematic representation 
of a microswimmer propelled by bubbles32. (B) Schematic representation of an Au-Ni-Au nanowire 
propelled by ultrasound and guided by an external magnetic field32. (C) Schematic representation of the 
corkscrew motion of a magnetic helix in the presence of a rotating magnetic field33. (D) Schematic 
representation of the motion of Janus particles by light-induced phoretic self-propulsion34. 
 
 
 4 𝐴𝑔𝐶𝑙 + 2𝐻2𝑂 
    ℎ𝑣,   𝐴𝑔+
→        4 𝐴𝑔 + 4 𝐻+ + 4 𝐶𝑙− + 𝑂2 (1) 
 
 
This reaction is illustrated in Figure 5A. As a result of the photodecomposition of 
silver chloride, a local chemical gradient is self-generated and thus the Janus 
microswimmers move due to self-diffusiophoresis36. The mechanism of self-
diffusiophoresis is illustrated in Figure 5B, where it is visible that the generated ions 
diffuse at different rates, leading to a net electric field pointing towards the Janus 
cap37.  
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Figure 5. (A) Schematic illustration of the photodecomposition reaction of the AgCl cap triggered by 
blue light illumination36. (B) Schematic representation of the self-diffusiophoresis mechanism near an 
AgCl particle37. 
 
Since the Janus micromotors are generating a chemical gradient, passive particles 
present in solution can interact with it. Positive charged particles would be pumped 
and electrostatically attached to the Janus micromotors, while negative charged 
particles would move away from the Janus micromotors creating an exclusion zone 
around them28,29. The exclusion behavior is illustrated in Figure 6. The forces 
generated around the Janus particles remain active even when they are fixed at the 
substrate. 
 
 
Figure 6. Exclusion behavior of pasive silica particles around Janus PS/Ag/AgCl. Interaction of a 
single Janus particle fixed at the substrate with passive silica particles at (a) 0.1 s, (b) 0.2 s, and (c) 0.3 
s. (d) Schematic illustration of the blue-light induced exclusion process between a cluster of Janus 
PS/Ag/AgCl and passive silica particles. Figure adapted from Wang et al.29 
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Overall, these interesting phenomena make the Janus PS/Ag/AgCl micromotors a 
suitable non-biological model to study cell signaling and collective behavior28. 
Furthermore, the coordinated motion makes them attractive for applications such as 
transport and cargo delivery, chemical sensing, biomedical and environmental 
remediation29.  
1.5 Aim 
The increasing demand to develop more accurate diagnostic tests that can be 
employed even in the most remote parts of the world where there are no specialized 
laboratories has led to the integration of different technologies that can aid to fulfill 
these requirements. The aim of this master thesis is to contribute to overcome this 
challenge by introducing the preliminary work of a LOC system for POC testing.  
 
In summary, the main purpose of this work is to perform an indirect agglutination 
assay in micrometer sized wells using Janus micromotors to enhance the interaction 
between functionalized particles and antibodies. This concept is illustrated in Figure 
7.  
 
 
Figure 7. Conceptual schematic representation of the microswimmer-activated agglutination assay. (A) 
Janus microswimmer promotes the exclusion of functionalized particles when it is illuminated with 
blue light. When the light is turned off, the exclusion disappears. (B) When IgM antibody is present, 
the Janus microswimmer would promote the interaction of the functionalized particles and the 
antibody, allowing them to agglutinate. When the light is turned off, the particles will remain in 
clusters. 
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The first part of this work involves the fabrication and characterization of the main 
elements needed to perform the proposed assay: microwell chips as reaction 
chambers, Janus PS/Ag/AgCl micromotors as agglutination promoters, and 
functionalized particles for the agglutination assay. The second part of the thesis 
studies the interaction of the Janus micromotors with different particles, and the third 
and final section addresses the implementation of the indirect agglutination assay.  
 
It is believed that systems similar to the proposed one can reduce assay time and 
detect lower analyte concentrations. In addition, this type of systems could be 
integrated with, for example, impedimetric-based sensors that would be able to 
monitor the agglutination of the particles with respect to different analyte 
concentrations and, as a result, they would be able to give more accurate and 
quantitative results.  
 
The work realized during this master thesis provides the first steps towards the 
implementation of a fully-integrated lab-on-a-chip agglutination assay for point-of-
care testing.  
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2. Materials and Methods 
2.1 Microwell fabrication 
Following a common UV-photolithography process, 40 micrometer-sized wells were 
fabricated to perform the proposed agglutination assay. Starting from cleaned glass 
slides, a thin layer of Ti-Prime (MicroChemicals GmbH) was deposited at 4000 rpm 
for 50 s and further baked at 120°C for 2 min to assure adhesion of the glass substrate 
and the subsequent coating. A 15 µm thick SU-8 (MicroChem) layer was then 
deposited with a spin coater RC 8 (Karl Suss) followed by a pre-baking step at 95°C 
for 6 min. The SU-8 coated substrate was then exposed to UV light (SUSS MicroTec) 
for 7.5 s and post-baked for 12 min at 95°C. To obtain the final structure the SU-8 
was developed in mrDev600 (micro resist technology GmbH) for 4 min using 
ultrasonic bath, rinsed with isopropanol and hard-baked at 180°C for 1 h. These steps 
are summarized in Figure 8. 
 
 
Figure 8. Schematic representation of the UV-photolitography process followed for the fabrication of 
microwells (40 µm in diameter). (1) The process started with a cleaned was slide. (2) Ti-prime was 
deposited and baked for 2 min. (3) SU-8 was deposited and pre-baked. (4) The resist was exposed to 
UV-light using a mask with the appropriate design to obtain 40 µm wells. SU-8 was post-baked, 
developed and rinse. (5) Final structure obtained after being hard-baked. (6) Microwells with PEG 
layer. 
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The agglutination assay involves the use of proteins which are known to have 
nonspecific absorption to hydrophobic substrates such as SU-8 and glass38,39. To 
prevent this, a poly(ethylene glycol) (PEG) layer was formed over the fabricated 
microwells. The substrates containing the microwells were treated with atmospheric 
oxygen plasma (Zepto system, Diener electronic GmbH) at 100 W for 1 min to 
expose OH- groups on the surface. Then, the substrates were placed in a 1% PEG 
(Sigma-Aldrich, mol wt. 8000) solution for 10 min and dried using N2 gun. To 
remove any remaining solvent, the substrates were baked at 100°C for 10 min.  
2.2 Microswimmers fabrication 
The fabrication of light-driven Janus PS/Ag/AgCl microswimmers begins with the 
formation of a monolayer of 2 µm PS particles (Sigma-Aldrich). This monolayer was 
achieved by drop casting the PS particles in ethanol suspension (25 mg/mL) over 
water covered glass slides previously processed by atmospheric oxygen plasma. The 
monolayer forms at the air-water interface and it was transferred to the glass slides 
(that are located at the bottom) by carefully removing the water from the edges using 
a pipette. Once the solvent was removed and the glass slides were air dried, the 
monolayer of PS particles was located on the surface of the glass slides. A 60 nm Ag 
layer was then deposit on the upper side of the monolayer by electron beam 
deposition. The Ag covered PS particles were suspended in DI water. To convert the 
Ag into AgCl, the Janus particles were dispersed in a 0.02 M FeCl3 (Sigma-Aldrich) 
solution and an excess of 50 mM PVP (Sigma-Aldrich) solution was added. This 
reaction was performed in dark environment at room temperature for 1 h with 
constant stirring. When reaction was finished, the particles were washed five times 
and suspended in deionized (DI) water for further use. The schematic representation 
of the fabrication process of the Janus microswimmers is depicted in Figure 9. 
2.3 Functionalization of particles 
To perform an agglutination assay, micrometer-sized passive particles have to be 
functionalized with the appropriate antigen or antibody. For this thesis, 1.01 µm SiO2-
NH2 particles (Bangs Laboratories, Inc.) and 2.12 µm SiO2-NH2 particles 
(microParticles GmbH) were functionalized with goat anti-human IgM secondary 
antibody (ThermoFischer) following the protocol for covalent coupling of Bangs 
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Figure 9. Schematic representation of the fabrication process of Janus particles. (1) A PS monolayer is 
formed over a glass slide. (2) A 60 nm thick layer of Ag is deposited on the upper side of the 
monolayer creating a half coating. (3) The particles are detached from the substrate and suspended in a 
solution of FeCl3 and PVP to convert the Ag into AgCl. This reaction was performed in dark 
environment. (4) After Ag oxidation, particles are suspended in DI water and store in dark environment 
until used.  
 
Laboratories40. The amount of secondary antibody needed to saturate the surface of 
the particles was estimated using the following equation: 
 Sd)(C)(6/ S   (2) 
 
where S is the amount of antibody required for surface saturation, ρS is the density of 
the particle, d is the mean diameter of the particle and C is the capacity of the particle 
surface for a given antibody40. The value of C used to calculate S was 2.5 mg/m2 41.  
 
The process started with washing 3.3 mg of 1.01 µm SiO2-NH2 particles and 7.14 mg 
of 2.12 µm SiO2-NH2 particles 2 times in 10 ml wash buffer (PBS, pH 7.4, Sigma-
Aldrich). After second wash the particles were suspended in 10 ml of glutaraldehyde 
(Sigma-Aldrich) solution (glutaraldehyde dissolved in wash buffer to 10% final 
concentration) for 2 h at room temperature with constant stirring. After 2 h, the 
particles were washed 2 times and further suspended in 5 ml of wash buffer. The 5 ml 
particle suspension was combined with 0.005 mg of goat anti-human IgM secondary 
antibody previously diluted in 5 ml of wash buffer and allowed to react at room 
temperature for 4 h with continuous mixing. Once the reaction was finished, the 
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particles were washed 2 times (supernatant should be store to verify the 
functionalization) and suspended in quenching solution (35 mM glycine, 1% w/v 
BSA, Sigma-Aldrich) for 30 min with gentle mixing. Finally, the particles were 
washed 2 times, suspend in storage buffer (PBS with 0.01% w/v BSA) and store at 
4°C until used. 
 
2.4 Characterization of particles 
2.4.1 Scanning electron microscope  
The scanning electron microscope (SEM) allows observation of materials within the 
nanometer and micrometer scale. With this instrument you can obtain 3-dimensional 
images of the surface of materials42. To verify the fabrication of the Janus 
Ps/Ag/AgCl particles, SEM micrographs were acquired at 10 kV with a XL30 
(Philips/FEI) SEM. 
2.4.2 UV-vis spectroscopy 
UV-vis spectroscopy is a quantitative technique that is based on the interaction of 
light with matter. This technique is widely employed to calculate the concentration of 
proteins in solution by measuring the absorbance at 280 nm and using Lambert-Beer 
law43. At his particular wavelength, the aromatic amino acids tyrosine and tryptophan 
exhibit a strong light absorption; as a consequence, the absorption of a protein at 280 
nm is proportional to the content of these amino acids44.  
 
UV-vis spectroscopy was used to verify the binding of goat anti-human IgM 
secondary antibodies attached to the surface of the 1.01 and 2.12 µm SiO2-NH2 
particles.  The amount of free protein in solution after the reaction was determined by 
a standard curve using a UV-6300PC double beam spectrophotometer (VWR). The 
absorbance of the supernatants of both sizes of particles was measured and the 
concentration was calculated using a linear regression equation.  
2.4.3 Zeta potential  
The movement of colloids has a direct dependency on the value of the zeta potentials 
of the particles involved and the walls surrounding them28,45. The zeta potential 
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characterizes the electrical double layer of a solid surface and its value can be used to 
discuss the interactions between solid-solid and solid liquid interfaces46,47. 
  
To understand how the particles used in this work were moving and interacting with 
each other, zeta potential measurements were performed using Zetazizer Nano ZSP 
(Malvern Panalytical) with a 10 mW red laser (632.8 nm). 
2.4.4 Optical microscopy 
Optical microscopy allows us to observe in the micrometer scale, and with the 
addition of digital imaging, we are capable of acquiring not only single images, but 
also to record interesting processes48. 
 
To visualize the effect of the Janus particles on different particles (passive and 
functionalized) and the agglutination of the functionalized particles when the 
agglutinating agent was added to solution, an inverted Axiovert 200 M microscope 
(Carl Zeiss) integrated with a 5120 (Cascade) video camera was used.  
 
The videos were recorded at 14 fps using two types of light illuminations: green light 
for reference measurements and blue light to generate the photodecomposition of 
AgCl since the plasmonic Ag/AgCl cap of the Janus particles enables them to absorb 
at this wavelength. The green light was obtained from the microscope halogen lamp 
(12V, 100 W) and filter sets in green and yellow color. The blue light was provided 
by an external fluorescent lamp HBO103 (Carls Zeiss). The images and videos were 
analyzed using the software Fiji49.   
2.5 Motion Experiments  
Two experiments were performed to visualize the effect of the chemical gradient 
around the Janus particle and different particles (passive and functionalized): 
exclusion time and on/off light cycles. 
 
Janus particles were fixed at the bottom of the fabricated microwells and subsequently 
5 µl of particles (passive or functionalized) were added. For the exclusion time 
experiment, the microwells containing the Janus particles and the passive or 
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functionalized particles were illuminated with blue light for 2 min. For the on/off light 
cycles experiment, the microwells containing the Janus particles and the passive or 
functionalized particles were illuminated in an alternating way for 10 s with blue light 
and 30 s without blue light for 3 min.  
2.6 Agglutination assay 
The agglutination assay was performed using two different substrates: microscope 
glass slides with a PEG layer and the fabricated microwells. 5 µl of functionalized 
particles (1.01 µm and 2.12 µm) was deposited over the substrate and subsequently 5 
µl of Human IgM (Sigma-Aldrich) with a concentration of 500 ng/ml were used as 
agglutinating agent. Images were taken just after adding the Human IgM and as the 
experiment progressed. 
 
To verify the agglutination, a negative control for each size of functionalized particles 
was realized by depositing 5 µl of functionalized particles over both substrates 
without the addition of the Human IgM. Images were taken just after adding the 
functionalized particles and as the experiment progressed. 
 
Agglutination assay was also performed using the Janus particles that were fixed at 
the bottom of the microwells. The experiments were realized following the 
methodology of section 2.5, the only difference was the addition of Human IgM as 
agglutination agent.  
2.7 Effect of PBS  
2.7.1 Janus particles 
Janus particles were suspended in different PBS concentrations (50, 5, and 0.5 mM) 
and deposited inside the microwells to study the effect of PBS on their motion. The 
particles were illuminated with blue light for 30 s and their trajectories were tracked 
using the software Fiji. The motion in PBS was compared to the motion of Janus 
particles suspended in DI water. 
 17 
2.7.2 Agglutination assay 
To verify the binding ability of the antibodies at low PBS concentrations, an 
agglutination assay was performed over a PEG-covered glass slide using 5 µl of 2 µm 
SiO2–NH2-Ab particles and 5 µl of Human IgM.  
2.7.3 Exclusion of functionalized particles 
To analyze the interaction of Janus and 2 µm SiO2–NH2-Ab particles at low PBS 
concentration, Janus particles were fixed at the bottom of the microwells and 
subsequently 5 µl of 2 µm SiO2–NH2-Ab suspended in 0.5 mM PBS concentration 
were added. The particles were illuminated with blue light for 30 s. 
 
  
 
 
 18 
3. Results and Discussion 
3.1 Microwell chip with integrated Janus particles 
An optical microscope image of one of the fabricated microwellchips is shown in 
Figure 10A. The size of the microwells was elected so that it was possible to have a 
clear visualization of the Janus particles and the microwell at the same time. Since the 
Janus particles show active motion when illuminated with blue light, their trajectories 
do not remain in the same observation plane during the experiments. As a result, it is 
difficult to have a clear perspective of the influence of the flows produced by the 
photocatalytic reaction at the surface of the Janus particles on passive and 
functionalized particles. To overcome this situation, Janus particles were fixed at the 
bottom of the fabricated microwells as shown in Figure 10B.  
 
Figure 10. (A) Microwell chip. (B) Two Janus particles fixed at the bottom of a microwell. SEM 
images of one Janus particle (C) and various assemblies of Janus particles (D). 
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The presence of the Ag/AgCl cap of the fabricated Janus particles can be observed in 
the SEM images shown in Figure 10C-D. Apart from the single Janus particles, 
different assemblies of particles are visible. This is a consequence of the hydrophobic 
metal cap which causes the interaction between Janus particles in solution29. 
3.2 Characterization of particles 
3.2.1 UV-vis spectroscopy 
To verify the functionalization of the SiO2-NH2 particles, the absorbance of goat anti-
human IgM was measured at known concentrations to obtain the standard curve 
shown in Figure 11. With a linear regression analysis Equation 3 was obtained: 
  𝑦 = −0.0034 + 4.4542 𝑥 (3) 
where y-axis designates the absorbance in A.U. and x-axis designates the goat anti-
human IgM concentration in mg/ml.  
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Figure 11. Standard curve for goat anti-human IgM. 
 
With this analysis, it was possible to estimate the concentration of goat anti-human 
IgM in solution after the functionalization. This result shows the amount of goat anti-
human IgM that was not covalently attached to the particles and since the initial 
concentration of antibody is known, the amount of antibody retained by the particles 
can be calculated. These results are reported in Table 1. 
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Table 1. Absorbance of supernatants at 280 nm, calculated concentration of goat anti-human IgM 
remaining in solution, amount of goat anti-human IgM covalently attached to the particles and amount 
of particles used for functionalization. 
Sample  Absorbance 
of 
supernatant 
(A.U.) 
Concentration goat 
anti-human IgM in 
supernatant  
(mg/ml) 
Goat anti-human 
IgM attached to the 
particles  
(mg) 
Weight 
of 
particles 
(mg) 
 
1 µm SiO2 –NH2 0.0036 0.0016  0.0034 3.3 
2 µm SiO2 –NH2 0.0033 0.0015 0.0035 7.14 
 
Equation 2 suggests that the amount of secondary antibody needed to achieve surface 
saturation of 1 g of 1 µm and 2 µm SiO2 –NH2 particles was 7.5 mg and 3.5 mg 
respectively. It is recommended to use up to 10 times of the amount of secondary 
antibody that is necessary to obtain a monolayer when finding the optimal 
concentration for the functionalization since the coupling efficiency for different 
particles might vary. Particle composition, surface groups, surface charge density and 
hydrophilicity have an effect on the proximity of the antibody with the surface groups 
of the particle so that covalent coupling can be achieved. 
 
For the functionalization, the initial concentration of goat anti-human IgM was 0.0050 
mg/ml for both sizes of SiO2 –NH2 particles and 3.3 mg of 1 µm SiO2 –NH2 and 7.14 
mg 2 µm SiO2 –NH2 particles were used so that the amount of secondary antibody 
was 2 times the amount needed to obtain a monolayer. As a result, it was expected that 
after the functionalization the amount of secondary antibody remaining in solution 
was the same for both sizes of particles, that is, half of the initial concentration. As it 
is shown in Table 1, the concentration of free secondary antibody in solution is 
approximately the same for both supernatants, but the concentration is less than 
expected. This can be due to the fact that for the calculation made using Equation 2, 
the value of C used was for bovine IgG with a molecular weight of 160 kD41. This 
value was experimentally obtained by Cantero et al. by adding different 
concentrations of antibody and measuring the amount of antibody that was absorbed 
by polystyrene tubes until saturation was reached41. Since the goat anti-human IgM 
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secondary antibody is an IgG with different characteristics from bovine IgG and it 
was attached to SiO2–NH2 particles that exhibit different properties compared to 
polystyrene tubes, the value of C is expected to differ from the one used. To have a 
better understanding of the capacity of the SiO2–NH2 particles for goat anti-human 
IgM secondary antibody, a similar experiment to the one performed by Cantero et al. 
should be realized.  
3.2.2 Zeta potential 
The main objective of this work was to achieve the motion of functionalized particles 
by means of the fluids generated around Janus particles when these are illuminated 
with blue light. To understand the interactions between the particles and their 
surroundings, the zeta potential of each of the particles used for the experiments was 
measured and it is reported in Table 2.  
 
When a particle with net charge is suspended in a medium, an electrical double layer 
would form around it. Due to the charge of the particle, opposite charged ions are 
adsorbed to the surface and these ions would further attract the corresponding 
counterions, thus covering the surface of the particle with an electrical double 
layer50,51. This means that the same particle with different surface groups would have 
a different electrical double layer, and since the zeta potential characterizes the 
electrical double layer, the value of the zeta potential can be seen as an indicator of 
the functionalization of the particles.  
Table 2. Zeta potential values for the different particles involved in the experiments.  
Sample Zeta potential 
(mV) 
1  µm  SiO2 –NH2 59.2 
2  µm  SiO2 –NH2 68.03 
1  µm  SiO2 –NH2-Ab  -7.94 
2  µm  SiO2 –NH2-Ab  -7.10 
2  µm  SiO2  -38.76 
PS/Ag/AgCl -27 ± 2.429  
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As shown in Table 2, before functionalization, both sizes of particles had a positive 
zeta potential, 59.2 mV for 1 µm and 68.03 mV for 2 µm particles. After 
functionalization the particles changed their zeta potential to -7.94 mV for 1 µm and -
7.10 mV for 2 µm. This change in the value of the zeta potential was expected since 
the surface of the particles no longer had the amino groups exposed, but the secondary 
antibodies, whose charge is depended on their amino acid sequence, content and the 
pH of the medium52,53. 
3.2.3 Agglutination assay in PEG-covered glass slides  
The final verification of the functionalization of the SiO2 –NH2 particles was done by 
performing an agglutination assay using an IgM concentration of 500 ng/ml. The 
results of the agglutination assay (top row) and the negative control (bottom row) for 
both sizes of particles are shown in Figure 12.  
 
Figure 12. Agglutination assay performed over PEG-covered glass. Top row corresponds to the assay 
and bottom row to the negative control. A-D corresponds to 1 µm SiO2–NH2-Ab. E-H corresponds to 2 
µm SiO2 –NH2-Ab particles. Scale bar is 10 µm. 
 
The agglutination assay performed with 1 µm SiO2–NH2-Ab particles showed 
aggregation in clusters of size of approximate 10 particles, in addition some single 
particles were observed. The corresponding negative control exhibited small clusters 
of approximate 3 particles, while the majority of the particles were in a non-
aggregated state. This result strongly indicates the functionalization of particles, as 
they aggregate in the presence of IgM, whereas the functionalized particles in the 
absence of IgM remained in a non-aggregated state.  
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The agglutination assay performed with 2 µm SiO2–NH2-Ab particles clearly showed 
that the particles aggregated in particular shapes, compared to the negative control 
that showed minimal association of particles. The linear and branched- like shapes of 
the clusters depicted in Figure 12F are similar to the resulting structures of a 
diffusion-limited aggregation (DLA) process54. This is applicable to cluster formation 
in which the particles have to diffuse to interact and agglomerate, such as the case of 
the agglutination assay54. A simulation of a structure formed by DLA process is 
shown in Figure 13.  
 
 
Figure 13. Simulation of the evolution of cluster formation of a growth model that describes the 
clustering of clusters of particles using 1024 particles. (a) Shows 86 clusters, (b) 8 clusters, and (c) 1 
cluster55. 
 
3.3 Motion experiments  
Motion experiments were realized to observe how passive SiO2 particles, SiO2–NH2 
particles, and functionalized SiO2–NH2-Ab particles respond to the flows generated 
around the Janus particles.  
3.3.1 Exclusion time   
Janus particles in presence of passive SiO2 particles, SiO2–NH2 particles, and 
functionalized SiO2–NH2-Ab particles were illuminated continuously for 2 min with 
blue light. The response of each of the particles is shown in Figure 14.  
 
Passive SiO2 particles were excluded from the Janus particles (Figure 14A-C) while 
the SiO2–NH2 particles moved towards the Janus particles (Figure 14D-F for 1µm and 
Figure 14G-I). This opposite behavior can be explained by analyzing the 
diffusiophoretic interaction between the Janus particle and passive SiO2 particles and 
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SiO2–NH2 particles. When Janus particles are illuminated with blue light, the AgCl 
located in the cap of the Janus particle will be photochemically decomposed as shown 
in Equation 128,56. As explained by Wang et al., this reaction results in a radial flow of 
the produced ions from the surface of the Janus particle which will induce the self-
propulsion of the Janus particles as well as the interaction with other particles present 
in the solution 29.  
 
The produced ions during the photodecomposition of the AgCl cap have different 
diffusion rates which lead to a net electric field that is pointing towards the cap of the 
Janus particle (see Figure 5) 28,37. This electric field will act phoretically on the 
particles and osmotically on any close electrical double layer28. As described by Ibele 
et al., particles with a positive zeta potential, such as the SiO2–NH2 particles used 
here, will be phoretically pumped towards the Janus particles and will be 
electrostatically attached to them since the zeta potential of the Janus particles is 
negative28. In contrast, particles with a negative zeta potential, such as the passive 
SiO2 particles used, will be phoretically excluded from the Janus particles. 
 
Figure 14B shows that the exclusion of passive SiO2 particles around a Janus particle 
after 30 s of blue light illumination forms an exclusion zone of approximate 10 µm in 
diameter. After 2 min of constant blue light illumination the exclusion zone is no 
longer visible (Figure 14C). This is a consequence of the silver metal depositing back 
to the Janus particle cap28,37. This would cover the AgCl of the Janus cap not allowing 
the photodecomposition to continue.  
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Figure 14. Exclusion time: the interaction of Janus particles and passive SiO2 particles (A-C), 1 µm 
SiO2–NH2 (D-F), 2 µm SiO2–NH2 (G-H), 1 µm SiO2–NH2-Ab (J-L), 2 µm SiO2–NH2-Ab (M-O), while 
being exposed to blue light for 2 min. Scale bar is 10 µm. 
 
The response of the functionalized particles to the flows produced by the Janus 
particles when illuminated with blue light are shown in Figure 14J-L for 1 µm SiO2–
NH2-Ab and in Figure 14M-O for 2 µm SiO2–NH2-Ab. Since the zeta potential of 
both sizes of particles is negative, it was expected that they would be excluded from 
 26 
the Janus particles; however, the functionalized particles do not show any noticeable 
response. This can be a consequence of the small value of the zeta potential and to the 
ions present in solution considering that the functionalized particles were dispersed in 
PBS solution. Both contributions will be briefly discussed in the following 
paragraphs. 
 
The motion of particles as a result of an ionic gradient can be explained by the 
contribution of two effects: the electrophoretic force and the fluid flow generated by 
electro-osmosis28,37,45. Even though the Janus particles are fixed to the surface of the 
microwells, when illuminated with blue light flows and forces are generated around 
them as if they were suspended in solution29. The electric force that is generated 
around the Janus particles would exclude away particles with a negative zeta potential 
and attract particles with positive zeta potential45. However, the strength of the 
electric force directly depends on the value of the zeta potential of the particle, if the 
value of zeta potential is not sufficient, the electric force would not be enough to 
induce a motion on the particles. In this work, the functionalized particles have a zeta 
potential which is small compered to the values of zeta potential of particles that have 
shown either exclusion or attraction to the Janus particles. 
 
As mentioned before, the electric field generated by the ionic gradient contributes to 
the motion of diffusiophoretic particles. When other ions are present in the bulk 
solution, they can screen the electric field. As a result, when increasing the 
concentration of ions in solution, the speed of diffusiophoretic particles decreases 
significantly28. This implies that the forces around the Janus particles are not enough 
to propel it, and this suggest that there will be no effect (exclusion or attraction) on 
other particles that are present in solution. 
3.3.2 On/off light cycles   
The results of the interaction of passive SiO2 particles, 1 µm SiO2–NH2, 2 µm SiO2–
NH2, 1 µm SiO2–NH2-Ab, 2 µm SiO2–NH2-Ab while being exposed to alternating 
blue light for 10 s on and 30 s off are shown in Figure 15. Each column represents a 
complete experiment of the type of particles mentioned at the top of the column.This 
experiment can be considered as a negative control since no IgM is added. 
 27 
 
Figure 15. Interaction of Janus particles and passive SiO2 particles (A), 1 µm SiO2–NH2 (B), 2 µm 
SiO2–NH2 (C), 1 µm SiO2–NH2-Ab (D), 2 µm SiO2–NH2-Ab (E), while being exposed to alternating 
blue light for 10 s on and 30 s off. Scale bar is 10 µm. 
 
The aim of this thesis was to demonstrate the Janus particles could act as 
agglutination promoters considering that the flows produced around them promote the 
interaction (exclusion or attraction) of other particles present in solution. For that 
reason, it was expected that when IgM was present in solution the interaction between 
the particles would be irreversible. The purpose of the experiment of alternating light 
cycles was to have a clear visualization of the agglutination of particles. Without IgM 
it was expected that particles would exclude (or attract) the Janus particle when blue 
light is on and relax when the light is off (negative control), and with IgM it was 
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expected that particles would exclude (or attract) and remain in that state when the 
light is turned off. 
 
The results of the negative control when passive SiO2 particles are used clarly shows 
the concept explained in the previous paragraph. At time 0 s, passive SiO2 particles 
are in close contact with the Janus particle. When blue light is on, the particles are 
excluded away from the cap. After 10 s of blue light illumination the particles relax 
and come around the Janus particle. When illuminated again, the particles are 
excluded and then relax back once the light is off. As explained before, silver metal 
produced during photodecomposition coats back into the cap blocking the AgCl 
available for reaction. As a result the size of the exclusion zone at time 50 s is slightly 
smaller than the size of the exclusion zone at 10 s. 
 
From the results from section 3.3.1, it was expected to observe the same behaviour 
with SiO2–NH2 particles but with attraction of the particles to the Janus particles 
instead of being excluded. However, the electrostatic interaction between the Janus 
particles and the SiO2–NH2 particles was very strong, thus the particles were not able 
to relax (Figure 15B-C). 
 
By virtue of the results reported in the previous section it was anticipated that the 
functionalized SiO2–NH2-Ab particles would not have any response during the light 
cycles. This can be confirmed in the columns D and E from Figure 15. 
3.4 Agglutination assay 
3.4.1 Assay performed in wells 
Before executing the agglutination assays using Janus particles as agglutination 
promoters, agglutination assays without Janus particles were performed with both 
sizes of functionalized SiO2–NH2-Ab particles. The results are presented in Figure 16. 
 
Both sizes of functionalized particles show agglutination compared to their respective 
controls. The sizes of the aggregates formed by 1 µm SiO2–NH2-Ab are comparable 
to those shown in Figure 12B. However, with respect to Figure 12F, the sizes of the 
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aggregates formed by 2 µm SiO2–NH2-Ab are smaller. This can be a result of the 
amount of particles that are inside the microwell. There are fewer particles inside the 
microwell that are available to interact than the amount of particles that are interacting 
in Figure 12E-F.         
 
Figure 16. Agglutination assay performed microwells. Top row corresponds to the assay and bottom 
row to the negative control. A-D corresponds to 1 µm SiO2–NH2-Ab. E-H corresponds to 2 µm SiO2 –
NH2-Ab particles. Scale bar is 10 µm. 
 
3.4.2 Assay performed in wells with Janus particles 
The results of these experiments were thought to probe that Janus particles could act 
as agglutination promoters during agglutination assays. However, as it has been 
previously discussed, the functionalized particles do not respond to the flows and 
forces produced around the Janus particle when illuminated with blue light. 
Therefore, it was expected that no interaction of the functionalized particles and the 
Janus particles would have happened. That can be confirmed in Figure 17B for 1 µm 
SiO2–NH2-Ab and in Figure 17F for 2 µm SiO2–NH2-Ab.  
 
Despite that there was no visible interaction between the Janus particles and the 
functionalized particles agglutination was expected since IgM was present in solution. 
In Figure 17B for 1 µm SiO2–NH2-Ab and in Figure 17F for 2 µm SiO2–NH2-Ab, 
some agglutination of the functionalized particles is visible. 
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Figure 17. Agglutination assay performed microwells in presence of Janus particles. Top row 
corresponds to the assay and bottom row to the negative control. A-D corresponds to 1 µm SiO2–NH2-
Ab. E-H corresponds to 2 µm SiO2 –NH2-Ab particles. Scale bar is 10 µm. 
 
3.5 Effect of PBS concentration 
3.5.1 Janus particles 
As discussed in section 3.3.1, the extra ions provided by the functionalized particles 
suspended in PBS could affect the the propulsion of the Janus particles, and, as a 
result, no interaction between the Janus particles and functionalized particles was 
observed. However, antibodies (in this case goat anti-human IgM and human IgM) 
work under physiological conditions which requiere the use of PBS and a pH of 7.4. 
For that reason it is important that the Janus particle can generate flows around itself 
in physiological conditions. 
 
The motion of the Janus particles was studied under different concentrations of PBS 
to observe how the speed changes compare to the motion of Janus particles in water. 
Figure 18 shows the results of the motion of the Janus particles being illuminated for 
30 s. The tracking column displays the trajectory of the moving particles from time 0 
s to 30 s. 
 
At high concentrations of PBS (50 and 5 mM) the majority of the Janus particles are 
fixed at the substrate and the ones that move show only Brownian motion. At 0.05 
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mM concentration of PBS, Janus particles exhibit some displacement; however, the 
trajectory followed in DI water is considerable larger.  
 
Figure 18. Effect of PBS on the motion of Janus particles. A-C Janus particles in 50 mM PBS. D-F 
Janus particles in 5 mM PBS. G-I Janus particles in 0.5 mM PBS. J-L Janus particles in DI water. Scale 
bar is 10 µm. 
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3.5.2 Agglutination assay 
As it was previously mentioned, physiological conditions are required for the 
agglutination assay to work properly. On the other hand, to be able to use the Janus 
particles as agglutination promoters, the concentration of ions present in solution 
should be reduced. A compromise has to be reached to find the conditions in which 
the Janus particles could act as agglutination promoters and the antibodies maintain 
their functionalities. 
 
As seen in the previous section the Janus particles exhibit some motion at 0.5 mM 
PBS concentration. For that reason, the agglutination of particles was tested with 2 
µm SiO2 –NH2-Ab particles suspended in 0.5 mM PBS. The results of the 
agglutination assay are shown in Figure 19. 
 
 
Figure 19. Agglutination assay using 2 µm SiO2 –NH2-Ab particles suspended in 0.5 mM PBS 
solution. Scale bar is 10 µm. 
 
After 4 min, the agglutination of the particles is evident. This result, in addition to the 
results from the previous section, might suggest that 0.5 mM PBS is a suitable 
concentration for the test. Nevertheless, the IgM is supplied in PBS and since equal 
volumes of IgM and functionalized particles were used, the final concentration of 
PBS during this assay was higher than 0.5 mM.  
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Achieving a final concentration of 0.5 mM is not so straightforward considering that a 
dilution of IgM would imply less IgM available for interaction and, in the end, 
agglutination might not be visible. A careful methodology should be designed to 
obtain a suitable concentration of IgM for agglutination to happen and a suitable 
concentration of PBS so that both the Janus particles and the antibodies can work 
properly. 
3.5.3 Exclusion of functionalized particles  
To test if the concentration of PBS at which Janus particles exhibit some motion had 
an effect on the interaction with 2 µm SiO2 –NH2-Ab particles, a Janus particle was 
fixed at the bottom of a well and it was illuminated for 30 s with blue light in the 
presence of 2 µm SiO2 –NH2-Ab suspended in 0.5 mM PBS concentration.  
 
Figure 20. Interaction of Janus particle with 2 µm SiO2 –NH2-Ab particles suspended in 0.5 mM PBS 
solution. 
 
As it can be seen in Figure 20, the Janus particle is not able to induce exclusion on the 
surrounding 2 µm SiO2 –NH2-Ab particles. This result together with results reported 
in section 3.5.1 give some important insight into the parameters that should be 
carefully modified to achieve the agglutination of functionalized particles promoted 
by the interaction with the Janus particles. 
 
The results of the effect of the PBS concentration on the motion of the Janus particles 
showed that the motion is considerably affected by the ions present in solution. 
However, since even at low concentration of PBS the Janus particles were not able to 
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exclude the functionalized particles, this suggests that the value of the zeta potential is 
of great importance to achieve exclusion, as it was discussed in section 3.3.1. 
 
The results obtained in this work provide the basis to achieve the agglutination of 
particles using Janus particles as agglutination promoters. It was found that the proper 
working conditions for the used antibodies and the Janus particles differed and as a 
result the interaction between the functionalized particles and the Janus particles was 
not visible. However, the key parameters affecting the interaction between the 
particles were discussed. Further experiments should be performed to find the 
conditions in which the concentration of IgM would be enough to produce 
agglutination, and the concentration of PBS is such that the Janus particles and the 
antibodies maintain their activities.  
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4. Conclusions 
The interaction between Janus particles and passive SiO2 particles, SiO2–NH2 
particles, and functionalized SiO2–NH2-Ab particles was presented. Depending on the 
charge of the particles, attraction (for particles with positive zeta potential) or 
exclusion (particles with negative zeta potential) was observed. However, the 
magnitude of the zeta potential and the extra ions present in solution (ions from PBS 
solution) affected the fluid and forces produced around the Janus particles. As a result, 
particles suspended in PBS solution and with small zeta potential could not show any 
interaction with the Janus particles. 
 
Motion experiments at different PBS concentrations showed that the movement of the 
Janus particles is considerably affected by the extra ions in solution. Only at 0.5 mM 
PBS concentration some motion vas observed, however it was minimal compare to 
motion of Janus particles in DI water. At this concentration of PBS, no exclusion is 
visible between the Janus and functionalized SiO2–NH2-Ab particles. This suggests 
that the value of zeta potential has a great influence on the exclusion of the 
functionalized particles.  A more negative zeta potential of the functionalized particles 
should be achieved to have visible exclusion. 
 
The results of the agglutination assays demonstrate that the particles were properly 
functionalized since in presence of IgM the particles form agglomerates. When the 
agglutination assay was performed in presence of the Janus particles, agglutination 
was visible but no exclusion of the functionalized particles was observed.  
 
Agglutination assay was performed at 0.5 mM concentration of PBS since higher PBS 
concentrations greatly affect the flows and forces that are formed around the Janus 
particles. Agglutination of functionalized particles was visible at these conditions; 
however, the effective PBS concentration was higher due to the fact that the IgM is 
provided in PBS.  
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In summary, the proper working conditions for the antibodies and the Janus particles 
differed and, as a consequence, no interaction between the Janus and functionalized 
particles was visible. Taking into account the key parameters that affect the 
interaction between the particles (extra ions in solution and magnitude of the zeta 
potential), further experiments should be performed to find the conditions at which 
the concentration of PBS would allow the Janus particles and the antibodies to 
maintain their activities, and the concentration of IgM is enough to produce 
agglutination. 
 
The work realized in the course of this master thesis provides the first steps towards 
the development of a lab-on-a-chip agglutination assay for point-of-care testing. 
 
 
 37 
References 
1. Naumov, L. B. Main problems of modern medicine in diagnostics and learning: 
ways of optimal solution. Anadolu Kardiyol Derg 1, 166–178 (2001). 
2. Kosack, C. S., Page, A.-L. & Klatser, P. R. Policy &amp; practice A guide to 
aid the selection of diagnostic tests. Bull World Heal. Organ 95, 639–645 
(2017). 
3. Organization, W. H. Laboratory and in vitro diagnostics. (2019). Available at: 
https://www.who.int/in-vitro-diagnostic/en/. (Accessed: 15th July 2019) 
4. Leeflang, M. M. G. & Allerberger, F. How to: evaluate a diagnostic test. Clin. 
Microbiol. Infect. 25, 54–59 (2019). 
5. Commission, E. The In Vitro Diagnostic Medical Devices Directive 
(98/79/EC). Off. J. Eur. Communities 7.12 (1998). 
6. Cheng, C.-M., Kuan, C.-M. & Chen, C. In-vitro diagnostic devices: 
Introduction to current point-of-care diagnostic devices. (2015). 
doi:10.1007/978-3-319-19737-1 
7. Lee, G. C. et al. Development and evaluation of a rapid diagnostic test for 
Plasmodium falciparum, P. vivax, and mixed-species malaria antigens. Am. J. 
Trop. Med. Hyg. 85, 989–993 (2011). 
8. Cai, H. Y., Caswell, J. L. & Prescott, J. F. Nonculture Molecular Techniques 
for Diagnosis of Bacterial Disease in Animals: A Diagnostic Laboratory 
Perspective. Vet. Pathol. 51, 341–350 (2014). 
9. Kwok, S. et al. Identification of human immunodeficiency virus sequences by 
using in vitro enzymatic amplification and oligomer cleavage detection. J. 
Virol. 61, 1690–4 (1987). 
10. Saiki, R. K. et al. Enzymatic amplification of beta-globin genomic sequences 
and restriction site analysis for diagnosis of sickle cell anemia. 1985. 
Biotechnology 24, 476–480 (1992). 
11. O’Donnell, O. Access to health care in developing countries: breaking down 
demand side barriers. Cad. Saude Publica 23, 2820–34 (2007). 
12. Vashist, S. K. Point-of-care diagnostics: Recent advances and trends. 
Biosensors 7, 10–13 (2017). 
 38 
13. Koczula, K. M. & Gallotta, A. Lateral flow assays. Essays Biochem. 60, 111–
120 (2016). 
14. Singer, J. M. & Plotz, C. M. The Latex Fixation Test: I. Application to the 
Serologic Diagnosis of Rheumatoid Arthritis. American Journal of Medicine 
21, 888–892 (1956). 
15. Stavitsky, A. B. Agglutination. in Encyclopedia of Immunology (Second 
Edition) (ed. Delves, P. J.) 56–59 (Elsevier, 1998). 
doi:https://doi.org/10.1006/rwei.1999.0016 
16. Austin, J. W. & Pagotto, F. J. MICROBIOLOGY | Detection of Foodborne 
Pathogens and their Toxins. in Encyclopedia of Food Sciences and Nutrition 
(Second Edition) (ed. Caballero, B.) 3886–3892 (Academic Press, 2003). 
doi:https://doi.org/10.1016/B0-12-227055-X/00774-4 
17. Fronczek, C. F. & Yoon, J.-Y. Chapter 12 - Detection of Foodborne Pathogens 
Using Biosensors. in Antimicrobial Food Packaging (ed. Barros-Velázquez, J.) 
153–166 (Academic Press, 2016). doi:https://doi.org/10.1016/B978-0-12-
800723-5.00012-7 
18. Lumen Learning. Agglutination Assays. Available at: 
https://courses.lumenlearning.com/suny-microbiology/chapter/agglutination-
assays/. (Accessed: 1st April 2019) 
19. Gupta, A. & Chaudhary, V. K. Whole-blood agglutination assay for on-site 
detection of human immunodeficiency virus infection. J. Clin. Microbiol. 41, 
2814–2821 (2003). 
20. Branch, S. L. & Levett, P. N. Evaluation of four methods for detection of 
immunoglobulin M antibodies to dengue virus. Clin. Diagn. Lab. Immunol. 6, 
555–7 (1999). 
21. Chew, D. J., DiBartola, S. P. & Schenck, P. A. Chapter 14 - Tumors of the 
Urinary System. in Canine and Feline Nephrology and Urology (Second 
Edition) (eds. Chew, D. J., DiBartola, S. P. & Schenck, P. A.) 434–464 (W.B. 
Saunders, 2011). doi:https://doi.org/10.1016/B978-0-7216-8178-8.10014-4 
22. Lee, J. & Lee, S. H. Lab on a chip for in situ diagnosis: From blood to point of 
care. Biomed. Eng. Lett. 3, 59–66 (2013). 
23. Gupta, S., Kilpatrick, P. K., Melvin, E. & Velev, O. D. On-chip latex 
agglutination immunoassay readout by electrochemical impedance 
 39 
spectroscopy. Lab Chip 12, 4279–4286 (2012). 
24. Mohammed, M. I., Haswell, S. & Gibson, I. Lab-on-a-chip or Chip-in-a-lab: 
Challenges of Commercialization Lost in Translation. Procedia Technol. 20, 
54–59 (2015). 
25. Maria-Hormigos, R., Jurado-Sánchez, B. & Escarpa, A. Labs-on-a-chip meet 
self-propelled micromotors. Lab Chip 16, 2397–2407 (2016). 
26. Castillo-leon, J. Lab-on-a-Chip Devices and Micro-Total Analysis Systems. 
Lab-on-a-Chip Devices and Micro-Total Analysis Systems (2014). 
doi:10.1007/978-3-319-08687-3 
27. García, M. et al. Micromotor-based lab-on-chip immunoassays. Nanoscale 5, 
1325–1331 (2013). 
28. Ibele, M., Mallouk, T. E. & Sen, A. Schooling behavior of light-powered 
autonomous micromotors in water. Angew. Chemie - Int. Ed. 48, 3308–3312 
(2009). 
29. Wang, X. et al. Visible Light Actuated Efficient Exclusion Between Plasmonic 
Ag/AgCl Micromotors and Passive Beads. Small 14, (2018). 
30. Guix, M., Mayorga-Martinez, C. C. & Merkoçi, A. Nano/Micromotors in 
(Bio)chemical science applications. Chem. Rev. 114, 6285–6322 (2014). 
31. P. Feynman, R. There is plenty of room at the bottom.pdf. Eng. Sci. 23, 22–36 
(1960). 
32. Abdelmohsen, L. K. E. A., Peng, F., Tu, Y. & Wilson, D. A. Micro- and nano-
motors for biomedical applications. J. Mater. Chem. B 2, 2395–2408 (2014). 
33. Gao, W. et al. Bioinspired helical microswimmers based on vascular plants. 
Nano Lett. 14, 305–310 (2014). 
34. Dong, R., Zhang, Q., Gao, W., Pei, A. & Ren, B. Highly efficient light-driven 
TiO2-Au Janus Micromotors. ACS Nano 10, 839–844 (2016). 
35. Sanchez, S., Soler, L. & Katuri, J. Chemically powered micro- and 
nanomotors. Angew. Chemie - Int. Ed. 54, 1414–1444 (2015). 
36. Wang, X. et al. High-Motility Visible Light-Driven Ag/AgCl Janus 
Micromotors. Small 14, 1–11 (2018). 
37. Zhou, C., Zhang, H. P., Tang, J. & Wang, W. Photochemically Powered AgCl 
Janus Micromotors as a Model System to Understand Ionic Self-
Diffusiophoresis. Langmuir 34, 3289–3295 (2018). 
 40 
38. Tao, S. L., Popat, K. C., Norman, J. J. & Desai, T. A. Surface modification of 
SU-8 for enhanced biofunctionality and nonfouling properties. Langmuir 24, 
2631–2636 (2008). 
39. Yang, Z., Galloway, J. A. & Yu, H. Protein interactions with poly(ethylene 
glycol) self-assembled monolayers on glass substrates: Diffusion and 
adsorption. Langmuir 15, 8405–8411 (1999). 
40. Bangs Laboratory. Covalent Coupling. (2013). doi:10.1007/3-540-29623-
9_5754 
41. Cantarero, L. A., Butler, J. E. & Osborne, J. W. The adsorptive characteristics 
of proteins for polystyrene and their significance in solid-phase immunoassays. 
Anal. Biochem. (1980). doi:10.1016/0003-2697(80)90473-X 
42. Goldstein, J. I. et al. Introduction. in Scanning Electron Microscopy and X-ray 
Microanalysis: Third Edition 1–20 (Springer US, 2003). doi:10.1007/978-1-
4615-0215-9_1 
43. Pace, C. N., Vajdos, F., Fee, L., Grimsley, G. & Gray, T. How to measure and 
predict the molar absorption coefficient of a protein. Protein Sci. 4, 2411–2423 
(1995). 
44. Note, T. NanoDrop One/One C and Multiskan Sky spectrophotometers. 
45. Afshar Farniya, A., Esplandiu, M. J. & Bachtold, A. Sequential tasks 
performed by catalytic pumps for colloidal crystallization. Langmuir 30, 
11841–11845 (2014). 
46. Anderson, J. Colloid Transport By Interfacial Forces. Annu. Rev. Fluid Mech. 
21, 61–99 (1989). 
47. Hunter, R. J. Zeta potential in colloid science: principles and applications 
(Vol.2). (Academic Press, 2013). 
48. Davidson, M. W. & Abramowitz, M. Optical Microscopy. in Encyclopedia of 
Imaging Science and Technology (American Cancer Society, 2002). 
doi:10.1002/0471443395.img074 
49. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. 
Nat. Methods 9, 676 (2012). 
50. Park, S.-J. & Seo, M.-K. Chapter 1 - Intermolecular Force. in Interface Science 
and Composites (eds. Park, S.-J. & Seo, M.-K.) 18, 1–57 (Elsevier, 2011). 
51. Selvamani, V. Chapter 15 - Stability Studies on Nanomaterials Used in Drugs. 
 41 
in Characterization and Biology of Nanomaterials for Drug Delivery (eds. 
Mohapatra, S. S., Ranjan, S., Dasgupta, N., Mishra, R. K. & Thomas, S.) 425–
444 (Elsevier, 2019). doi:https://doi.org/10.1016/B978-0-12-814031-4.00015-5 
52. Welch, N. G., Scoble, J. A., Muir, B. W. & Pigram, P. J. Orientation and 
characterization of immobilized antibodies for improved immunoassays 
(Review). Biointerphases 12, 02D301 (2017). 
53. Gitlin, I., Carbeck, J. D. & Whitesides, G. M. Why are proteins charged? 
Networks of charge-charge interactions in proteins measured by charge ladders 
and capillary electrophoresis. Angew. Chemie - Int. Ed. 45, 3022–3060 (2006). 
54. Witten, T. A. & Sander, L. M. Diffusion-limited aggregation. 27, 5686–5697 
(1983). 
55. Kolb, M., Botet, R. & Jullien, R. Scaling of Kinetically Growing Clusters. 
Phys. Rev. Lett. 1123–1126 (1983). 
56. Calzaferri, G. At the time he made the first photographs on paper: Did Henry 
Fox Talbot oxidize water to oxygen with sunlight? Catal. Today (1997). 
doi:10.1016/S0920-5861(97)82240-7 
 
 42 
Declaration of Research Integrity and Good Scientific Practice 
 
 
I hereby certify that I have authored this Master’s Thesis entitled Microswimmer-
activated agglutination assay and without undue assistance from third parties. No 
other than the resources and references indicated in this thesis have been used. I have 
marked both literal and accordingly adopted quotations as such. They were no 
additional persons involved in the spiritual preparation of the present thesis. I am 
aware that violations of this declaration may lead to subsequent withdrawal of the 
degree.  
 
Dresden, Germany, August 5th, 2019.  
 
 
Diana Isabel Sandoval Bojórquez 
